Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands.

The highly pathogenic H5N1 influenza virus, which is rapidly mutating and becoming increasingly drug-resistant, was investigated by means of structure-activity relationship between NA (neuraminidase) and three inhibitors, i.e., DANA (2,3-didehydro-2-deoxy-N-acetylneuraminic acid), zanamivir, and oseltamivir. A homology model of the H5N1-NA from the highly pathogenic chicken H5N1 A viruses isolated during the 2003-2004 influenza outbreaks in Japan was built based on the crystal structure of N9-NA complexed with DANA (PDB code: 1F8B). It was found that the traditional constituent residues around the active site of NA family are highly conserved in the H5N1-NA. However, a partially lipophilic pocket composed by Ala248 and Thr249 in N9-NA becomes a hydrophilic pocket because the two residues in the H5N1-NA are replaced by hydrophilic residues Ser227 and Asn228, respectively. On the other hand, two hydrophilic residues Asn347 and Asn348 in the N9-NA are replaced by two lipophilic residues Ala323 and Tyr324 in the H5N1-NA, respectively, leading to the formation of a new lipophilic pocket. This kind of subtle variation not only destroys the original lipophilic environment but also changes the complement interaction between the H5N1-NA and DANA. Such a finding might provide insights into the secret why some of H5N1 strains bear high resistance for existing NA inhibitors, and stimulate new strategies for designing new drugs against these viruses.

[1]  I. Miller,et al.  Zanamivir: a review of clinical safety. , 1999, Drug safety.

[2]  K. Chou.  Structural bioinformatics and its impact to biomedical science. , 2004, Current medicinal chemistry.

[3]  Thomas F. Smith,et al.  Avian Influenza: A New Pandemic Threat? , 2004, Mayo Clinic Proceedings.

[4]  Louise Wickham,et al.  Post-translational Processing of β-Secretase (β-Amyloid-converting Enzyme) and Its Ectodomain Shedding , 2001, The Journal of Biological Chemistry.

[5]  A. Pohorille,et al.  An information theory model of hydrophobic interactions. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[6]  N. Katunuma,et al.  Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. , 1992, The Journal of biological chemistry.

[7]  Louise Wickham,et al.  Post-translational processing of β-secretase (BACE) and its ectodomain shedding: the pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid Aβ production , 2001 .

[8]  Kuo-Chen Chou,et al.  Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. , 2004, Biochemical and biophysical research communications.

[9]  Gerhard Wagner,et al.  Solution Structure of the RAIDD CARD and Model for CARD/CARD Interaction in Caspase-2 and Caspase-9 Recruitment , 1998, Cell.

[10]  T. A. Jones,et al.  Using known substructures in protein model building and crystallography. , 1986, The EMBO journal.

[11]  Kuo-Chen Chou,et al.  Modeling the tertiary structure of human cathepsin-E. , 2005, Biochemical and biophysical research communications.

[12]  V. Garsky,et al.  The Pro Domain of β-Secretase Does Not Confer Strict Zymogen-like Properties but Does Assist Proper Folding of the Protease Domain* , 2001, The Journal of Biological Chemistry.

[13]  Dapeng Li,et al.  Heuristic molecular lipophilicity potential (HMLP): Lipophilicity and hydrophilicity of amino acid side chains , 2006, J. Comput. Chem..

[14]  K. Chou,et al.  Prediction of the tertiary structure and substrate binding site of caspase‐8 , 1997, FEBS letters.

[15]  Kuo-Chen Chou,et al.  Molecular therapeutic target for type-2 diabetes. , 2004, Journal of proteome research.

[16]  K. Goa,et al.  Zanamivir , 1999, Drugs.

[17]  David S. Goodsell,et al.  Distributed automated docking of flexible ligands to proteins: Parallel applications of AutoDock 2.4 , 1996, J. Comput. Aided Mol. Des..

[18]  L. Tsai,et al.  Structure and Regulation of the CDK5-p25nck5a Complex , 2001 .

[19]  S. Narula,et al.  The carboxyl-terminal region of human interferon gamma is important for biological activity: mutagenic and NMR analysis. , 1991, Protein engineering.

[20]  Kuo-Chen Chou,et al.  Energy of stabilization of the right-handed βαβ crossover in proteins☆ , 1989 .

[21]  J. McKimm-Breschkin,et al.  Resistance of influenza viruses to neuraminidase inhibitors--a review. , 2000, Antiviral research.

[22]  W G Laver,et al.  Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors. , 1998, Journal of medicinal chemistry.

[23]  Kuo-Chen Chou,et al.  Insights from modelling the 3D structure of the extracellular domain of alpha7 nicotinic acetylcholine receptor. , 2004, Biochemical and biophysical research communications.

[24]  J L Sussman,et al.  A 3D building blocks approach to analyzing and predicting structure of proteins , 1989, Proteins.

[25]  T. L. Blundell,et al.  Knowledge-based prediction of protein structures and the design of novel molecules , 1987, Nature.

[26]  Kuo-Chen Chou,et al.  The convergence‐divergence duality in lectin domains of selectin family and its implications , 1995, FEBS letters.

[27]  G. Air,et al.  Distribution of sequence differences in influenza N9 neuraminidase of tern and whale viruses and crystallization of the whale neuraminidase complexed with antibodies. , 1987, Virology.

[28]  K D Watenpaugh,et al.  A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator. , 1999, Biochemical and biophysical research communications.

[29]  J. Oxford,et al.  New Millennium Antivirals against Pandemic and Epidemic Influenza: The Neuraminidase Inhibitors , 2002, Antiviral chemistry & chemotherapy.

[30]  Brian J Smith,et al.  Structural studies of the resistance of influenza virus neuramindase to inhibitors. , 2002, Journal of medicinal chemistry.

[31]  N. Thornberry,et al.  The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis , 1996, Nature Structural Biology.

[32]  Brian J. Smith,et al.  Analysis of inhibitor binding in influenza virus neuraminidase , 2001, Protein science : a publication of the Protein Society.

[33]  Kuo-Chen Chou,et al.  Prediction of the Tertiary Structure of the β-Secretase Zymogen☆ , 2002 .

[34]  G. Air,et al.  Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding , 1995, Journal of virology.

[35]  S. Wodak,et al.  Modelling the polypeptide backbone with 'spare parts' from known protein structures. , 1989, Protein engineering.

[36]  N. Cox,et al.  Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. , 1998, Science.

[37]  Kuo-Chen Chou,et al.  Heuristic molecular lipophilicity potential (HMLP): A 2D‐QSAR study to LADH of molecular family pyrazole and derivatives , 2005, J. Comput. Chem..

[38]  Kuo-Chen Chou.  Insights from modeling three-dimensional structures of the human potassium and sodium channels. , 2004, Journal of proteome research.

[39]  A. Tomasselli,et al.  The atomic-resolution structure of human caspase-8, a key activator of apoptosis. , 1999, Structure.

[40]  G. Air,et al.  Three-dimensional structures of influenza virus neuraminidase-antibody complexes. , 1989, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[41]  Qishi Du,et al.  Theoretical Derivation of Heuristic Molecular Lipophilicity Potential: A Quantum Chemical Description for Molecular Solvation , 2005, J. Chem. Inf. Model..

[42]  Yoshihiro Kawaoka,et al.  Pandemic Threat Posed by Avian Influenza A Viruses , 2001, Clinical Microbiology Reviews.

[43]  M. Kiso,et al.  Characterization of H5N1 influenza A viruses isolated during the 2003-2004 influenza outbreaks in Japan. , 2005, Virology.

[44]  G. Air,et al.  Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site. , 1999, Journal of molecular biology.

[45]  C. Silagy,et al.  Effectiveness and role of zanamivir in the treatment of influenza infection. , 1999, Annals of medicine.

[46]  Kuo-Chen Chou,et al.  Identification of the N‐terminal functional domains of Cdk5 by molecular truncation and computer modeling , 2002, Proteins.

[47]  K. Chou,et al.  Prediction of the tertiary structure of a caspase‐9/inhibitor complex , 2000, FEBS letters.

[48]  Kuo-Chen Chou,et al.  Insights from modeling the tertiary structure of human BACE2. , 2004, Journal of proteome research.

[49]  D. Schomburg,et al.  Prediction of protein three-dimensional structures in insertion and deletion regions: a procedure for searching data bases of representative protein fragments using geometric scoring criteria. , 1995, Journal of molecular biology.